| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 18.05.
| CEL-SCI Corporation Releases Letter to Shareholders | | 74 | Business Wire |
| The following letter was provided to shareholders by CEL-SCI
Corporation (NYSE MKT: CVM) for today's annual shareholder meeting:
Dear Fellow Shareholders:
...
Mehr lesen zu:
CEL-SCI Corporation Releases Letter to Shareholders | |
| 15.05.
| CEL-SCI's Chief Scientific Officer Presents at Cancer Symposium | | 37 | Business Wire |
| CEL-SCI Corporation (NYSE MKT: CVM) announced that its Chief
Scientific Officer, Eyal Talor, Ph.D., is making a presentation at 4:30
p.m. today in New York at the New...
Mehr lesen zu:
CEL-SCI's Chief Scientific Officer Presents at Cancer Symposium | |
| 11.05.
| Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System / Five Star Equities Provides Stock Research on Cardium Therapeutics and CEL-SCI | | 48 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/11/12 -- In recent months the Biotech Industry has become a hotbed of Merger and Acquisition (M&A) activity and speculation. As large pharmaceuticals face major...
Mehr lesen zu:
Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System / Five Star Equities Provides Stock Research on Cardium Therapeutics and CEL-SCI | |
| 10.05.
| Cel-Sci Says Phase III Clinical Trial Moving Forward | | 10 | Benzinga.com |
| 10.05.
| CEL-SCI Corporation Reports Second Quarter 2012 Financial Results | | 33 | Business Wire |
| CEL-SCI Corporation (NYSE AMEX: CVM) announced today financial
results for the fiscal quarter ended March 31, 2012.
CEL-SCI reported that net loss available...
Mehr lesen zu:
CEL-SCI Corporation Reports Second Quarter 2012 Financial Results | |
| 01.05.
| Cel-Sci Corp, Synergy Pharmaceuticals Stocks Rise: Investors Should Start Paying Attention | | 15 | Seeking Alpha |
| 21.03.
| BioMedReports: CEL-SCI's Technical Breakout Fueled By Improving Fundamentals | | 52 | Thomson Reuters ONE |
| Shares of Virginia based biotechnology company, CEL-SCI Corporation (AMEX: CVM) appear to be technically breaking out to the upside again. Â Interest and volume in the stock has been on the rise and...
Mehr lesen zu:
BioMedReports: CEL-SCI's Technical Breakout Fueled By Improving Fundamentals | |
| 19.03.
| CEL-SCI and Human Genome Sciences Poised to Benefit From Favorable Legislation / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | | 66 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 03/19/12 -- Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach....
Mehr lesen zu:
CEL-SCI and Human Genome Sciences Poised to Benefit From Favorable Legislation / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | |
| 06.03.
| CEL-SCI Corporation Pays off Convertible Debenture | | 33 | Business Wire |
| CEL-SCI Corporation (NYSE Amex: CVM) announced today that it has
fully paid off its outstanding convertible debenture. The Company had
been making monthly payments of...
Mehr lesen zu:
CEL-SCI Corporation Pays off Convertible Debenture | |
| 23.02.
| CEL-SCI and Threshold Pharmaceuticals on the Upswing as FDA Optimism Grows / The Paragon Report Provides Equity Research on CEL-SCI & Threshold Pharmaceuticals | | 97 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 02/23/12 -- Biotechnology stocks have performed well of late as companies from across the globe earn more investments. According to a report from Boulder-based data...
Mehr lesen zu:
CEL-SCI and Threshold Pharmaceuticals on the Upswing as FDA Optimism Grows / The Paragon Report Provides Equity Research on CEL-SCI & Threshold Pharmaceuticals | |
| 13.02.
| PennyStockCrew.com Volume Watch List: American Airlines (AMR), CEL-SCI Corporation (CVM), North Springs Resources (NSRS), Eastman Kodak (EK), Mustang Alliances (MSTG) / Discover Now How Getting Current Market Information On Break Away Penny Stocks Could | | 53 | MarketWire |
| PALM BEACH, FLORIDA -- (Marketwire) -- 02/13/12 -- www.PennyStockCrew.com The US leader in microcap alerts, offers its high quality stocks alert newsletter to investors looking for the best picks around!...
Mehr lesen zu:
PennyStockCrew.com Volume Watch List: American Airlines (AMR), CEL-SCI Corporation (CVM), North Springs Resources (NSRS), Eastman Kodak (EK), Mustang Alliances (MSTG) / Discover Now How Getting Current Market Information On Break Away Penny Stocks Could | |
| 09.02.
| CEL SCI CORP - 10-Q, Quarterly Report | | 8 | SEC Filings |
| 09.02.
| CEL-SCI Corporation Reports First Quarter 2012 Financial Results | | 49 | Business Wire |
| CEL-SCI Corporation (NYSE AMEX: CVM) reports financial results
for the fiscal quarter ended December 31, 2011.
CEL-SCI reported that net loss available to...
Mehr lesen zu:
CEL-SCI Corporation Reports First Quarter 2012 Financial Results | |
| 09.02.
| Corporate Profile's CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on CEL-SCI Corporation | | 25 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 02/09/12 -- Corporate Profile's financial website www.CPreports.com announces Ray Dirks article on CEL-SCI Corporation (NYSE Amex: CVM).
To view the report go...
Mehr lesen zu:
Corporate Profile's CPreports.com Publishes Article by Ray Dirks of Ray Dirks Research on CEL-SCI Corporation | |
| 26.01.
| CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering | | 47 | Business Wire |
| CEL-SCI Corporation (NYSE AMEX: CVM), a late-stage oncology
company, has entered into definitive agreements to sell 16,000,000
shares of its common stock at a price per...
Mehr lesen zu:
CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering | |
| 25.01.
| Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | | 59 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/25/12 -- The biotechnology industry has performed well in the early stages of 2012. The iShares NASDAQ Biotechnology Index is presently up nearly eight percent month-on-month...
Mehr lesen zu:
Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | |
| 20.01.
| CEL-SCI Corporation Releases Letter to Shareholders | | 69 | Business Wire |
| The following letter is being released by CEL-SCI Corporation (NYSE
AMEX: CVM) to its shareholders:
Dear Fellow Shareholders:
With the...
Mehr lesen zu:
CEL-SCI Corporation Releases Letter to Shareholders | |
| 27.12.
| CEL-SCI (CVM) Expands Multikine Phase III to Spain, Czech Republic, Slovakia, Croatia | | 12 | StreetInsider.com |
| 23.12.
| CEL-SCI Corporation Announces Fiscal 2011 Financial Results | | 109 | Business Wire |
| CEL-SCI Corporation (NYSE AMEX: CVM) reported financial results
today for the fiscal year ended September 30, 2011.
CEL-SCI's net loss available to common...
Mehr lesen zu:
CEL-SCI Corporation Announces Fiscal 2011 Financial Results | |
| 08.12.
| Cel-Sci and Zalicus Make Headway in Recession Proof Biotech Sector / The Paragon Report Provides Equity Research on Cel-Sci & Zalicus | | 40 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 12/08/11 -- The Biotechnology industry has long been regarded as a "Recession Proof" sector of the economy. Even during periods of financial turmoil, most people will...
Mehr lesen zu:
Cel-Sci and Zalicus Make Headway in Recession Proof Biotech Sector / The Paragon Report Provides Equity Research on Cel-Sci & Zalicus | |
